Last Updated: 16 Sep 2024
Executive Summary
Orangekloud Technology Inc. (ORKT) is a technology company with a market capitalization of $104.65 million. The company has been experiencing financial difficulties, with negative EBITDA, EPS, and profit margins. However, the company's revenue has grown by 0.207% year-over-year. The latest stock price is $4.6.
Company Overview
Orangekloud Technology Inc. provides cloud-based solutions for businesses. The company's products include a cloud-based CRM, a cloud-based ERP, and a cloud-based business intelligence platform. Orangekloud Technology Inc. serves a variety of industries, including healthcare, education, and manufacturing.
Fundamental Analysis
Orangekloud Technology Inc.'s financial performance has been weak in recent quarters. The company has reported negative EBITDA, EPS, and profit margins. However, the company's revenue has grown by 0.207% year-over-year.
The company's balance sheet is also weak. Orangekloud Technology Inc. has a high level of debt and a low level of equity. This makes the company vulnerable to financial distress.
Technical Analysis
The technical analysis of Orangekloud Technology Inc.'s stock price shows that the stock is in a downtrend. The stock price has been making lower highs and lower lows since early 2022. The stock price is currently below its 50-day and 200-day moving averages.
Short Term Outlook
The short-term outlook for Orangekloud Technology Inc. is negative. The company's financial performance is weak and the stock price is in a downtrend. Investors should avoid buying ORKT stock in the short term.
Long Term Outlook
The long-term outlook for Orangekloud Technology Inc. is uncertain. The company's financial performance will need to improve significantly in order for the stock price to recover. Investors should only consider buying ORKT stock if they are willing to take on a high level of risk.
Analyst Recommendations
Analysts are currently recommending a "hold" rating on Orangekloud Technology Inc. stock. This means that analysts believe that the stock is fairly valued and that investors should not buy or sell the stock.
